Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide
- PMID: 8300232
- PMCID: PMC186166
- DOI: 10.1128/iai.62.2.722-725.1994
Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide
Abstract
In this study, it has been determined that immunoglobulin G1 (IgG1) and IgG3 monoclonal antibodies directed to the lipooligosaccharide A of Bordetella pertussis were able to protect mice from fatal aerosol infection. No correlation was found between the bactericidal activity in vitro in the presence of complement and the protection in mice, since a bactericidal IgG3 did not elicit protection. In addition, no significant difference in protective capacity was observed with bactericidal and nonbactericidal IgG1 antibodies, indicating that bactericidal activity is not a requirement for protection mediated by certain anti-lipooligosaccharide A antibodies. A reduction in protection in C5-deficient mice was observed, suggesting a significant role for complement in certain host defense mechanisms against B. pertussis infection.
Similar articles
-
A bactericidal monoclonal antibody specific for the lipooligosaccharide of Bordetella pertussis reduces colonization of the respiratory tract of mice after aerosol infection with B. pertussis.Infect Immun. 1992 Dec;60(12):5316-8. doi: 10.1128/iai.60.12.5316-5318.1992. Infect Immun. 1992. PMID: 1452367 Free PMC article.
-
Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.Infect Immun. 1990 Jan;58(1):7-16. doi: 10.1128/iai.58.1.7-16.1990. Infect Immun. 1990. PMID: 2294058 Free PMC article.
-
Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis.Springer Semin Immunopathol. 1993;15(2-3):205-15. doi: 10.1007/BF00201101. Springer Semin Immunopathol. 1993. PMID: 8256198 Review. No abstract available.
-
Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis.Clin Diagn Lab Immunol. 2001 Sep;8(5):1015-7. doi: 10.1128/CDLI.8.5.1015-1017.2001. Clin Diagn Lab Immunol. 2001. PMID: 11527820 Free PMC article.
-
Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis.Expert Rev Vaccines. 2014 Oct;13(10):1229-40. doi: 10.1586/14760584.2014.944901. Epub 2014 Aug 1. Expert Rev Vaccines. 2014. PMID: 25081731 Review.
Cited by
-
Non-primate animal models for pertussis: back to the drawing board?Appl Microbiol Biotechnol. 2022 Feb;106(4):1383-1398. doi: 10.1007/s00253-022-11798-1. Epub 2022 Feb 1. Appl Microbiol Biotechnol. 2022. PMID: 35103810 Free PMC article. Review.
-
Bordetella bronchiseptica-mediated cytotoxicity to macrophages is dependent on bvg-regulated factors, including pertactin.Infect Immun. 1999 Nov;67(11):5972-8. doi: 10.1128/IAI.67.11.5972-5978.1999. Infect Immun. 1999. PMID: 10531256 Free PMC article.
-
Toward a new vaccine for pertussis.Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3213-6. doi: 10.1073/pnas.1324149111. Epub 2014 Feb 20. Proc Natl Acad Sci U S A. 2014. PMID: 24556987 Free PMC article.
-
Role of gamma interferon in natural clearance of Bordetella pertussis infection.Infect Immun. 1997 Dec;65(12):4904-8. doi: 10.1128/iai.65.12.4904-4908.1997. Infect Immun. 1997. PMID: 9393774 Free PMC article.
-
An improved immunofluorescent reagent for rapid, direct detection of Bordetella pertussis.Can J Infect Dis. 1995 Jan;6(1):16-8. doi: 10.1155/1995/915203. Can J Infect Dis. 1995. PMID: 22514375 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous